ACCESS THE WHITEPAPER

Is your AI governance enabling innovation?

Five questions for healthcare leaders

As AI becomes embedded in care delivery, AI governance is a necessary safeguard. But what if it AI governance can be used not as a barrier to innovation, but as the mechanism that enables it?

Register to access the whitepaper which explores five questions healthcare leaders should ask as AI becomes more deeply embedded in clinical workflows. Drawing on emerging research and real-world governance challenges, the paper examines how health systems can move beyond viewing governance as a checkpoint and instead treat it as infrastructure for responsible scale.

The paper explores:

  1. Evidence governance: What evidence should clinicians trust?

  2. Provenance: Can clinicians see what supports the answer?

  3. Uncertainty: Can the system recognize when medicine does not have one answer?

  4. Human oversight: Where does clinical judgment add value?

  5. Continuous governance: What happens after implementation?

The whitepaper is built for leaders who want to ensure governance enables safe innovation rather than constraining it.

Author

IMG-Micromedex-Headshot-KainJ

Jack Kain, PharmD

Principal Architect and Clinical Consultant at Micromedex